ACTA has launched a new Industry Partnership Award in recognition of the important role that industry plays in Australian clinical trials.
Open to Members and non-members, the Industry Partnership Award will celebrate a significant collaboration between an industry company and a team of academic investigators uniting to conduct a high-impact clinical trial.
The winner of this new award will be publicly announced at ACTA’s National Tribute and Awards Ceremony, of which Bellberry are premium partners, held in Sydney on 20 May 2022 to coincide with International Clinical Trials Day. The annual awards honour Australians advancing our health system by designing, conducting, or participating in ground-breaking clinical trials and promote the importance of clinical trials and the expertise and complexity of the work involving trial teams, industry partners and consumers.
The closing date for nominations is midnight, Sunday 6 March 2022.
Visit ACTA for further information on the awards and to make your nomination.